G&S Capital’s Sanofi SNY Stock Holding History

G&S Capital’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-160	Closed	-$6K	–	176
2020 Q1	$6K	Hold	160	–	–	0.01%	150
2019 Q4	$8K	Hold	160	–	–	﹤0.01%	184
2019 Q3	$7K	Hold	160	–	–	﹤0.01%	185
2019 Q2	$7K	Hold	160	–	–	﹤0.01%	190
2019 Q1	$7K	Sell	160 -256	-62%	-$11K	﹤0.01%	187
2018 Q4	$18K	Buy	416 +256	+160%	+$11.3K	0.02%	134
2018 Q3	$7K	Hold	160	–	–	﹤0.01%	185
2018 Q2	$6K	Hold	160	–	–	﹤0.01%	183
2018 Q1	$6K	Hold	160	–	–	0.01%	173
2017 Q4	$7K	Buy	+160	New	+$7.38K	0.01%	180

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

G&S Capital's SNY Position: Q2 2020 in Review

G&S Capital sold out of Sanofi (SNY) in Q2 2020, closing a stake of 160 shares — an estimated $6K sold.

G&S Capital first reported a position in SNY in Q4 2017 and held it in 10 quarters. The position peaked at $18K in Q4 2018. 583 funds tracked by Wall St. Rank hold SNY as of Q2 2020.

G&S Capital reported no remaining Sanofi position as of Q2 2020 after selling out during the quarter.
G&S Capital sold 160 Sanofi shares in Q2 2020, an estimated $6K.
G&S Capital first reported a position in Sanofi in Q4 2017 and held it in 10 quarters.
G&S Capital's Sanofi position peaked at $18K in Q4 2018.
583 funds tracked by Wall St. Rank held Sanofi as of Q2 2020.

Based on G&S Capital's 13F filing for Q2 2020, filed 24 Jul 2020.